(Q30909780)

English

Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 June 2017

Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial (English)

1 reference

Europe PubMed Central

27 June 2017

1 reference

ChEBI release 2020-05-28

Eugene Braunwald

3

object named as

Eugene Braunwald

1 reference

Europe PubMed Central

27 June 2017

Robert P Giugliano

object named as

Robert P Giugliano

2

0 references

Elliott M Antman

14

object named as

Elliott M Antman

1 reference

Europe PubMed Central

27 June 2017

Sabina A Murphy

5

object named as

Sabina A Murphy

1 reference

Europe PubMed Central

27 June 2017

Christian C Ruff

1

object named as

Christian T Ruff

1 reference

Europe PubMed Central

27 June 2017

6

object named as

Julia F Kuder

1 reference

Europe PubMed Central

27 June 2017

Naveen Deenadayalu

7

object named as

Naveen Deenadayalu

1 reference

Europe PubMed Central

27 June 2017

Indravadan Patel

12

object named as

Indravadan Patel

1 reference

Europe PubMed Central

27 June 2017

Michele F Mercuri

13

object named as

Michele Mercuri

1 reference

Europe PubMed Central

27 June 2017

author name string

David A Morrow

4

1 reference

Europe PubMed Central

27 June 2017

Petr Jarolim

8

1 reference

Europe PubMed Central

27 June 2017

Joshua Betcher

9

1 reference

Europe PubMed Central

27 June 2017

Minggao Shi

10

1 reference

Europe PubMed Central

27 June 2017

Karen Brown

11

1 reference

Europe PubMed Central

27 June 2017

language of work or name

0 references

publication date

11 March 2015

1 reference

Europe PubMed Central

27 June 2017

1 reference

Europe PubMed Central

27 June 2017

385

1 reference

Europe PubMed Central

27 June 2017

2288-2295

1 reference

Europe PubMed Central

27 June 2017

9984

1 reference

Europe PubMed Central

27 June 2017

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961943-7

7 January 2021

based on heuristic

inferred from DOI database lookup

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961943-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961943-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961943-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961943-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961943-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961943-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Dabigatran versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961943-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961943-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Apixaban versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961943-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Edoxaban versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961943-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961943-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961943-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961943-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961943-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961943-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961943-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Anticoagulant options--why the FDA approved a higher but not a lower dose of dabigatran

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961943-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961943-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of anticoagulation intensity and management of bleeding with old and new oral anticoagulants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961943-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(14)61943-7

1 reference

Europe PubMed Central

27 June 2017

1 reference

Europe PubMed Central

27 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30909780&oldid=1744723475"